Study tests which diabetes drug better boosts natural insulin
NCT ID NCT07325435
Summary
This study compares how two types of FDA-approved diabetes medications affect the pancreas's ability to produce insulin in Black patients with type 2 diabetes. Sixty participants will take either a GLP-1 receptor agonist (like Ozempic) or an SGLT2 inhibitor (like Jardiance) for four months. Researchers will measure changes in insulin production and blood sugar control to see if one medication type works better for this population.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES (T2DM) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
SUNY Downstate Health Sciences University
Brooklyn, New York, 11203, United States
Conditions
Explore the condition pages connected to this study.